SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-053195
Filing Date
2024-05-06
Accepted
2024-05-06 07:05:11
Documents
12
Period of Report
2024-05-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K stok-20240506.htm   iXBRL 8-K 39518
2 EX-99.1 stok-ex99_1.htm EX-99.1 175789
  Complete submission text file 0000950170-24-053195.txt   342630

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT stok-20240506.xsd EX-101.SCH 24893
15 EXTRACTED XBRL INSTANCE DOCUMENT stok-20240506_htm.xml XML 4701
Mailing Address 45 WIGGINS AVENUE BEDFORD MA 01730
Business Address 45 WIGGINS AVENUE BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Filer) CIK: 0001623526 (see all company filings)

IRS No.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38938 | Film No.: 24915518
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)